FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0
- PMID: 33231504
- PMCID: PMC8342266
- DOI: 10.1177/0194599820969104
FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0
Abstract
Objective: FDG-PET/CT (fluorodeoxyglucose-positron emission tomography/computed tomography) is effective to assess for occult neck nodal disease. We report risks and patterns of nodal disease based on primary site and nodal level from data on the dissected cN0 per the results from ACRIN 6685.
Study design: Prospective nonrandomized enrollment included participants with first-time head and neck squamous cell carcinoma and at least 1 cN0 neck side to be dissected.
Setting: Twenty-four ACRIN-certified centers internationally (American College of Radiology Imaging Network).
Methods: A total of 287 participants were enrolled. Preoperative FDG-PET/CT findings were centrally reviewed and compared with pathology. Incidence, relative risk, pattern of lymph node involvement, and impact upon neck dissection were reported.
Results: An overall 983 nodal levels were dissected (n = 261 necks, n = 203 participants). The highest percentages of ipsilateral positive nodes by primary location and nodal level were oral cavity (level I, 17/110, 15.5%), pharynx (level II, 6/30, 20.0%), and larynx (level VI, 1/3, 33.3%).
Conclusion: Levels at greatest risk for nodal disease in cN0 in terms of ipsilateral neck dissection are level I (oral cavity), II (pharynx), and VI (larynx). These data should be considered when treating patients presenting with cN0. This is the first study to comprehensively report the incidence, location, and risk of metastases in cN0 in the FDG-PET/CT era.
Keywords: 18FDG-PET/CT; cN0; elective; head and neck squamous cell cancer; neck dissection.
Conflict of interest statement
Disclosures
Figures




Similar articles
-
Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.J Clin Oncol. 2019 Jul 10;37(20):1704-1712. doi: 10.1200/JCO.18.01182. Epub 2019 Feb 15. J Clin Oncol. 2019. PMID: 30768363 Free PMC article. Clinical Trial.
-
18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.Radiology. 2014 Apr;271(1):153-61. doi: 10.1148/radiol.13131470. Epub 2013 Nov 23. Radiology. 2014. PMID: 24475791
-
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):129-36. doi: 10.1016/j.ijrobp.2004.03.040. Int J Radiat Oncol Biol Phys. 2005. PMID: 15629603
-
Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.Am J Otolaryngol. 2019 Mar-Apr;40(2):297-305. doi: 10.1016/j.amjoto.2018.10.013. Epub 2018 Oct 23. Am J Otolaryngol. 2019. PMID: 30473166
-
PET/CT in Surgical Planning for Head and Neck Cancer.Semin Nucl Med. 2021 Jan;51(1):50-58. doi: 10.1053/j.semnuclmed.2020.07.009. Epub 2020 Aug 7. Semin Nucl Med. 2021. PMID: 33246539 Review.
Cited by
-
18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy-Results from Multicenter ACRIN 6685 Clinical Trial.J Nucl Med. 2022 Dec;63(12):1887-1890. doi: 10.2967/jnumed.122.263902. Epub 2022 May 12. J Nucl Med. 2022. PMID: 35552246 Free PMC article. Clinical Trial.
-
Role of 18F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications.Cancers (Basel). 2024 May 16;16(10):1905. doi: 10.3390/cancers16101905. Cancers (Basel). 2024. PMID: 38791983 Free PMC article. Review.
-
Quality of life following surgery for head and neck cancer: Evidence from ACRIN 6685.Head Neck. 2024 Aug;46(8):1988-1998. doi: 10.1002/hed.27673. Epub 2024 Feb 14. Head Neck. 2024. PMID: 38353324 Free PMC article. Clinical Trial.
-
Challenges of Pharyngeal Cancer Screening in Lower-Income Countries during Economic and Social Transitions: A Population-Based Analysis.Eur J Investig Health Psychol Educ. 2023 Oct 10;13(10):2226-2237. doi: 10.3390/ejihpe13100157. Eur J Investig Health Psychol Educ. 2023. PMID: 37887158 Free PMC article.
References
-
- Abu-Ghanem S, Yehuda M, Carmel NN, et al. Elective neck dissection vs observation in early-stage squamous cell carcinoma of the oral tongue with no clinically apparent lymph node metastasis in the neck: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2016;142(9):857–865. - PubMed
-
- Furukawa M, Dillon JK, Futran ND, Anzai Y. The prevalence of lymph node metastases in clinically CN0 necks with oral cavity squamous cell carcinoma: is CT good enough for nodal staging? Acta Radiol. 2014;55(5):570–578. - PubMed
-
- Lim YC, Koo BS, Lee JS, Lim JY, Choi EC. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the CN0 neck. Laryngoscope. 2006;116(7):1148–1152. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical